Avalon GloboCare
ALBT
ALBT was delisted on the 21st of July, 2026.
9 hedge funds and large institutions have $54.9K invested in Avalon GloboCare in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
13% more funds holding
Funds holding: 8 → 9 (+1)
0.51% less ownership
Funds ownership: 1.55% → 1.04% (-0.51%)
32% less capital invested
Capital invested by funds: $81.2K → $54.9K (-$26.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.9K |
| 2 |
Citigroup
New York
|
+$3.42K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$866 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$25 |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$14 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$5 |
| 2 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$5 |
ALBT Hedge Fund Activity: Q2 2025 in Review
9 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Avalon GloboCare (ALBT) for Q2 2025, worth a combined $54.9K — down 32% from $81.2K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ALBT positions and 2 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $5.9K. The largest seller was Fidelity Investments, exiting entirely with an estimated $5 sold.
- 9 institutional investors held Avalon GloboCare (ALBT) as of Q2 2025, up from 8 in Q1 2025.
- Funds reported $54.9K of Avalon GloboCare stock for Q2 2025, down 32% quarter-over-quarter.
- 3 funds opened new Avalon GloboCare positions in Q2 2025 and 2 closed out, a net change of +1 holder.
- The largest Avalon GloboCare buyer in Q2 2025 was UBS Group, an estimated $5.9K added.
- The largest Avalon GloboCare seller in Q2 2025 was Fidelity Investments, an estimated $5 sold.
Based on aggregated 13F filings for Q2 2025.